000 01343 a2200361 4500
005 20250517195122.0
264 0 _c20190107
008 201901s 0 0 eng d
022 _a1098-8823
024 7 _a10.1016/j.prostaglandins.2018.01.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHelmy, Mai M
245 0 0 _aZileuton alleviates acute cisplatin nephrotoxicity: Inhibition of lipoxygenase pathway favorably modulates the renal oxidative/inflammatory/caspase-3 axis.
_h[electronic resource]
260 _bProstaglandins & other lipid mediators
_c03 2018
300 _a1-10 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCaspase 3
_xmetabolism
650 0 4 _aCisplatin
_xadverse effects
650 0 4 _aHydroxyurea
_xanalogs & derivatives
650 0 4 _aKidney
_xdrug effects
650 0 4 _aLeukotriene B4
_xmetabolism
650 0 4 _aLeukotriene D4
_xmetabolism
650 0 4 _aLipoxygenases
_xmetabolism
650 0 4 _aMale
650 0 4 _aOxidative Stress
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
700 1 _aHashim, Amel A
700 1 _aMouneir, Samar M
773 0 _tProstaglandins & other lipid mediators
_gvol. 135
_gp. 1-10
856 4 0 _uhttps://doi.org/10.1016/j.prostaglandins.2018.01.001
_zAvailable from publisher's website
999 _c28001161
_d28001161